Among men smoking 1-2 packs, 13 percent had changes, and this increased to 23 percent among those smoking over 2 packs per day
Seven additional studies evaluated the efficacy of CHANTIX in patients with cardiovascular disease, in patients with chronic obstructive pulmonary disease [see Clinical Studies ], in patients instructed to select their quit date within days 8 and 35 of treatment [see Clinical Studies ], patients with major depressive disorder [see Clinical Studies ], patients who had made a previous attempt to quit smoking with CHANTIX, and either did not succeed in quitting or relapsed after treatment [see Clinical Studies ], in patients without or with a history of psychiatric disorder enrolled in a postmarketing neuropsychiatric safety outcome trial [see WARNINGS AND PRECAUTIONS , Clinical Studies ], and in patients who were not able or willing to quit abruptly and were instructed to quit gradually [see Clinical studies ]
The only difference is the source
This knowledge could influence how regulatory bodies approach SLT products
And thats not to mention the 28 chemicals in chewing tobacco known to cause cancer, like formaldehyde and arsenic
